<DOC>
	<DOCNO>NCT00427466</DOCNO>
	<brief_summary>The aim trial evaluate efficacy tolerability pemetrexed patient metastatic soft tissue sarcoma progress anthracycline-based chemotherapy ass toxicity profile</brief_summary>
	<brief_title>Pemetrexed Patients With Soft Tissue Sarcoma</brief_title>
	<detailed_description>One therapy cycle take total 3 week . On day 1 , Pemetrexed intravenously administer . The dosage 500 mg/m2 period 10 minute . A repetition procedure perform day 22</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Histologically confirm metastasize locally inoperable soft tissue sarcoma Progression relapse previous cytostatic treatment adriamycin and/or ifosfamide contain chemotherapeutic substance Twodimensionally measurable/evaluable tumor parameter ( accord WHOcriteria ) Previous radiotherapy acceptable long irradiated area include measurable lesion Patient compliance geographic proximity , ensure possibility adequate Followup Life expectancy 3 month ECOG &lt; = 2 Age least 18 year Adequate bone marrow function initiation therapy Adequate kidney function Patient consent Patient ability consent Previous concurrent irradiation indicator lesion Other concomitant tumor therapy Severe impairment hepatic function Active Infection Previous treatment Pemetrexed Second tumor within past 5 year ( except basal cell carcinoma , adequately treat carcinoma situ uterine cervix , bladder urothelium colon polyp include pTis pTin ) Severely symptomatic cardiovascular cerebrovascular disease HIV , active Hepatitis B C Dementia , Cerebral stroke cognitive deficit Kidney function &lt; = 79 ml/min ( calculate accord MDRD ) : Inability interrupt treatment NSAIDs/ASS/Cox2 Inhibitors 2 day prior follow administration Pemetrexed . If patient take NSAID salicylate long halflife take five day prior , day two day application Pemetrexed . Low dose acetyl salicylic acid administration permit ( e.g . 100 mg/die . ) There restriction kidney function great 80 ml/min . Inability unwillingness take folic acid , vitamin B12 dexamethasone Pleural pericardial exudate , ascites without drain ( 3rd Space ) Time Interval last course chemotherapy &lt; 4 week Symptomatic CNSMetastases Gravidity Lactation Women reproductive age without reliable contraception follow applies : Must surgically sterile , postmenopausal , compliant medically approve contraceptive regimen 3 month treatment Positive serum urine pregnancy test Participation another trial time</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>